Variant report

Variant	nsv1035229
Chromosome Location	chr11:107653731-107717190
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:26)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:2)

No data

(count:26 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:107670081..107670628-chr11:107695151..107695710,2	K562	blood:
2	chr11:107716345..107718524-chr11:107728424..107730206,2	K562	blood:
3	chr11:107711394..107713234-chr11:107715059..107718295,3	K562	blood:
4	chr11:107691036..107695039-chr11:107696173..107700652,4	K562	blood:
5	chr11:107701670..107703248-chr11:107728191..107729812,2	MCF-7	breast:
6	chr11:107663159..107665072-chr11:107667163..107669875,2	MCF-7	breast:
7	chr11:107693680..107695656-chr11:107699193..107701857,2	MCF-7	breast:
8	chr11:107709816..107713345-chr11:107727610..107729677,4	MCF-7	breast:
9	chr11:107646046..107648383-chr11:107654593..107656210,2	MCF-7	breast:
10	chr11:107663159..107665072-chr11:107667163..107669875,2	MCF-7	breast:
11	chr11:107691714..107693795-chr11:107728602..107730312,2	MCF-7	breast:
12	chr11:107705879..107708165-chr11:107709790..107712179,2	K562	blood:
13	chr11:107713214..107715442-chr11:107878460..107880889,2	K562	blood:
14	chr11:107693861..107695588-chr11:107701609..107703172,2	K562	blood:
15	chr11:107705879..107708165-chr11:107709790..107712179,2	K562	blood:
16	chr11:107711394..107713234-chr11:107715059..107718295,3	K562	blood:
17	chr11:107711008..107711755-chr20:47663245..47663778,2	Hela-S3	cervix:
18	chr11:107715556..107718513-chr11:107720703..107722662,2	K562	blood:
19	chr11:107689319..107691586-chr11:107728240..107730113,3	MCF-7	breast:
20	chr11:107670116..107670647-chr11:107768751..107769447,2	MCF-7	breast:
21	chr11:107716345..107719089-chr11:107728424..107730844,2	K562	blood:
22	chr11:107693680..107695656-chr11:107699193..107701857,2	MCF-7	breast:
23	chr11:107693861..107695588-chr11:107701609..107703172,2	K562	blood:
24	chr11:107670081..107670628-chr11:107695151..107695710,2	K562	blood:
25	chr11:107673752..107675731-chr11:107729272..107731917,2	MCF-7	breast:
26	chr11:107691036..107695039-chr11:107696173..107700652,4	K562	blood:

No data

(count:2 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	SLC35F2	hsa-miR-155-5p	chr11:107662756-107662777
2	SLC35F2	hsa-miR-155-5p	chr11:107675094-107675114

Variant related genes	Relation type
ENSG00000110660	chromatin interactions
ENSG00000166266	chromatin interactions

Extended variants
information (count: 2785 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:2785 , 50 per page) page: 1 2 3 4 5 6 7 ... 56

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs550996153	chr11:107653761-107653762	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs180878957	chr11:107653779-107653780	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs533354783	chr11:107653781-107653782	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs78680308	chr11:107653789-107653790	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs549267052	chr11:107653805-107653806	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs35508420	chr11:107653810-107653811	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs184751190	chr11:107653813-107653814	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs566605838	chr11:107653849-107653850	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs189671076	chr11:107653868-107653869	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs572060528	chr11:107653901-107653902	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs538517003	chr11:107653917-107653918	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs567554373	chr11:107653942-107653943	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs57278949	chr11:107653943-107653944	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs556964007	chr11:107653959-107653960	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs370330112	chr11:107653976-107653977	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs575527937	chr11:107654010-107654011	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs59414522	chr11:107654060-107654061	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs558002462	chr11:107654125-107654126	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs11212370	chr11:107654160-107654161	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs368056158	chr11:107654167-107654168	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs572943792	chr11:107654184-107654185	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs540342318	chr11:107654185-107654186	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs561622395	chr11:107654191-107654192	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs181515888	chr11:107654233-107654234	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs544237025	chr11:107654244-107654245	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs563024503	chr11:107654256-107654257	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs371597492	chr11:107654261-107654262	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs144215647	chr11:107654272-107654273	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs186695727	chr11:107654350-107654351	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs560322361	chr11:107654377-107654378	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs12285222	chr11:107654408-107654409	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs71488272	chr11:107654420-107654421	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs76054127	chr11:107654480-107654481	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs537834467	chr11:107654559-107654560	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs114955861	chr11:107654560-107654561	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs77606881	chr11:107654567-107654568	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs181918792	chr11:107654656-107654657	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs553862811	chr11:107654674-107654675	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs539762169	chr11:107654682-107654683	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs186453365	chr11:107654716-107654717	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs189705089	chr11:107654735-107654736	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs368524696	chr11:107654767-107654768	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs182648723	chr11:107654774-107654775	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs555161973	chr11:107654832-107654833	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs9804592	chr11:107654840-107654841	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs543841928	chr11:107654846-107654847	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs187967333	chr11:107654851-107654852	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs537312	chr11:107654871-107654872	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
49	rs572832319	chr11:107654876-107654877	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs11212371	chr11:107654889-107654890	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Cervical cancer	21062161	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	22429812	CNVD
Breast cancer	16608533	CNVD
T-cell lymphomas	19863542	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16785998	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21958427	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17603634	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Basal cell lymphoma	16790693	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Mental retardation	19966786	CNVD
Non-small cell lung cancer	21829676	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Intracranial aneurysm	16715129	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Urothelial carcinoma	21177765	CNVD
Myelofibrosis	22110671	CNVD
Ovarian cancer	21720365	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Glioblastoma multiforme	22286061	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Neuroblastoma	17327916	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Mantle cell lymphoma	19029149	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant melanoma	17260012	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	18632612	CNVD
Obesity	19966786	CNVD
Renal cell carcinoma	21668985	CNVD
Cancer	20164920	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Attention deficit hyperactivity disorder	19546859	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Cancer	17440070	CNVD

Chromatin state (count:956 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:107648400-107656000	Weak transcription	GM12878-XiMat	blood
2	chr11:107652000-107665000	Weak transcription	A549	lung
3	chr11:107653600-107654600	Enhancers	Osteobl	bone
4	chr11:107653800-107654000	Enhancers	NH-A	brain
5	chr11:107654000-107676800	Weak transcription	NH-A	brain
6	chr11:107654600-107655800	Weak transcription	Osteobl	bone
7	chr11:107655400-107657000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr11:107655400-107662800	Weak transcription	Rectal Mucosa Donor 31	rectum
9	chr11:107655800-107656600	Enhancers	Osteobl	bone
10	chr11:107655800-107657000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
11	chr11:107656000-107656200	Enhancers	GM12878-XiMat	blood
12	chr11:107656200-107656400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
13	chr11:107656200-107656600	Enhancers	iPS-15b Cell Line	embryonic stem cell
14	chr11:107656200-107656800	Enhancers	K562	blood
15	chr11:107656200-107662200	Weak transcription	GM12878-XiMat	blood
16	chr11:107656400-107656600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
17	chr11:107656400-107656600	Enhancers	Muscle Satellite Cultured Cells	--
18	chr11:107656400-107657800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
19	chr11:107656600-107658000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
20	chr11:107656600-107663000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
21	chr11:107656600-107673400	Weak transcription	Muscle Satellite Cultured Cells	--
22	chr11:107656600-107679800	Weak transcription	Osteobl	bone
23	chr11:107656800-107657000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr11:107656800-107673800	Weak transcription	K562	blood
25	chr11:107657000-107662200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
26	chr11:107657000-107662200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
27	chr11:107657000-107662600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr11:107657800-107658000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
29	chr11:107658000-107658800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
30	chr11:107658000-107659000	Enhancers	iPS-15b Cell Line	embryonic stem cell
31	chr11:107658200-107658600	Enhancers	Placenta Amnion	Placenta Amnion
32	chr11:107658200-107658800	Enhancers	HUES48 Cell Line	embryonic stem cell
33	chr11:107658200-107658800	Enhancers	NHEK	skin
34	chr11:107658200-107659200	Enhancers	HUES6 Cell Line	embryonic stem cell
35	chr11:107658200-107659200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
36	chr11:107658200-107659400	Enhancers	ES-I3 Cell Line	embryonic stem cell
37	chr11:107658400-107658600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
38	chr11:107658400-107658600	Enhancers	HUES64 Cell Line	embryonic stem cell
39	chr11:107658400-107659200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
40	chr11:107658600-107658800	Enhancers	H1 Cell Line	embryonic stem cell
41	chr11:107658600-107658800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr11:107658600-107662600	Weak transcription	Placenta Amnion	Placenta Amnion
43	chr11:107658600-107665600	Weak transcription	HUES64 Cell Line	embryonic stem cell
44	chr11:107658800-107660600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
45	chr11:107658800-107660800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
46	chr11:107658800-107662200	Weak transcription	NHEK	skin
47	chr11:107658800-107663200	Weak transcription	HUES48 Cell Line	embryonic stem cell
48	chr11:107658800-107679000	Weak transcription	H1 Cell Line	embryonic stem cell
49	chr11:107658800-107680600	Weak transcription	Small Intestine	intestine
50	chr11:107659000-107662400	Weak transcription	Duodenum Mucosa	Duodenum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links